{"id":"W3157976196","doi":"10.1111/apt.16388","title":"One‐year outcomes with ustekinumab therapy in infliximab‐refractory paediatric ulcerative colitis: a multicentre prospective study","year":2021,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa; Stollery Children's Hospital; Alberta Children's Hospital; Children's Hospital of Eastern Ontario; University of Calgary; University of Alberta; Hospital for Sick Children; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Western University; University of Toronto; SickKids Foundation","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Ustekinumab; Vedolizumab; Ulcerative colitis; Infliximab; Clinical endpoint; Internal medicine; Faecal calprotectin; Refractory (planetary science); Gastroenterology; Intention-to-treat analysis; Surgery; Calprotectin; Inflammatory bowel disease; Clinical trial; Tumor necrosis factor alpha; Disease","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002289783,0.0006428546,0.001106054,0.0009030036,0.0006868388,0.001380452,0.0007880447,0.00118512,0.001392159],"category_scores_gemma":[0.00427661,0.0004568332,0.001535249,0.001682017,0.0005971817,0.001072475,0.0008208459,0.001157106,0.0003606829],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008368902,"about_ca_system_score_gemma":0.0007701115,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002694852,"about_ca_topic_score_gemma":0.002376838,"domain_scores_codex":[0.9980807,0.0006378785,0.0002162486,0.0003868753,0.0003968124,0.0002814304],"domain_scores_gemma":[0.9937177,0.000641755,0.003730605,0.0003597299,0.00045796,0.001092265],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004331039,0.0003747928,0.991259,0.00009414166,0.0004900647,0.0002379351,0.0001233875,0.0001112752,0.0001382398,0.00002892962,0.0002249916,0.002586118],"study_design_scores_gemma":[0.0004277131,0.002998088,0.9949988,0.00003631855,0.0002694155,0.0005725994,0.0001016626,0.00009259674,0.00006763728,0.00001837732,0.0004007195,0.00001608558],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972689,0.001604005,0.00004962422,0.00004042211,0.00001176599,0.00004879312,0.0006195192,0.000003622352,0.0003533742],"genre_scores_gemma":[0.9975731,0.0006626848,0.0000879213,0.00005441864,0.00003354509,0.0000689712,0.001363234,0.00000386908,0.0001522532],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002694852,"threshold_uncertainty_score":0.0121097,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01589458324235767,"score_gpt":0.2921277296981889,"score_spread":0.2762331464558312,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}